In Vitro Thrombogenicity Tests of Factor IX Concentrates. II: Effects of Phospholipids and Heparin

Summary

Measurement of the total phospholipid (and that portion active in coagulation) in factor IX concentrates revealed no correlation with in vitro tests of potential thrombogenicity, except in the case of the recalcification time and the thrombin generation test which may detect coagulant phospholipid as well as the presence of thrombogenic enzymes. This is probably due to separation of the prothrombin complex proteins from most phospholipid during ion-exchange chromatography. Although low levels of phospholipid remain in the final product these are apparently insufficient to effect appreciable activation of factor IX concentrates despite low levels of antithrombin III.

Two tests which measure the formation of thrombin and factor Xa after recalcification of concentrates were affected by the addition of exogenous phospholipid. However this is a relative effect such that differences are quantitative rather than qualitative.

Heparin addition during production of factor IX concentrate was found to have only minor effects on the results of in vitro thrombogenicity tests of the final product. This was confirmed in the laboratory by incubation of unheparinised products with heparin for periods of up to 6 hr.

• References

• 1 Bell WN, Alton HG. 1954; A Brain Substitute for Platelet Suspensions in the Thromboplastin Generation Test. Nature 174: 880-881
• 2 Boffa MC, Boffa GA. 1976; A Phospholipase A² with Anticoagulant Activity. Biochem. Biophys. Acta 429: 839-852
• 3 Bradford MM. 1976; A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein. Analytical Biochemistry 72: 248-254
• 4 Chandra S, Wickerhauser M. 1978; Large Scale Preparation of Nonthrombogenic Prothrombin Complex. Thrombosis Research 12: 571-582
• 5 Godal HC, Gjengadal G. 1971; Activation of Coagulation by Heparin-Protamine Complexes as Demonstrated by Thrombotest. Scandinavian Journal of Haematology 8: 194-199
• 6 King JB. 1974; The Function of the Platelet Surface in Coagulation. Thrombosis, Diathesis et Haemorrhagica 32: 492-501
• 7 Kingdon HS, Lundblad RL, Veltkamp JJ, Aronson DL. 1975; Potentially Thrombogenic Materials in Factor IX Concentrates. Thrombosis, Diathesis et Haemorrhagica 33: 617-631
• 8 McClare CW F. 1971; An Accurate and Convenient Organic Phosphorus Assay. Analytical Biochemistry 39: 527-530
• 9 Ménache D, Roberts HR. 1975; Report of the Task Force on Clinical Use of Factor IX Concentrates. Thrombosis, Diathesis et Haemorrhagica 33: 645-647
• 10 Pepper DS, Banheygi D, Howie A. 1977; a Spectrophotometric Determination of Factor Xa Generation in Factor IX Concentrates. Thrombosis and Haemostasis 37: 535-540
• 11 Pepper DS, Banheygi D, Howie A, Cash JD. 1977; b In Vitro Thrombogenicity Tests of Factor IX Concentrates. British Journal of Haematology 36: 573-583
• 12 Prowse CV, Chirnside A, Elton RA. 1979 In Vitro Thrombogenicity Tests of Factor IX Concentrates. I. A survey of available assays - accompanying paper.
• 13 Sas G, Owens RE, Smith JK, Middleton S, Cash JD. 1975; In Vitro Spontaneous Thrombin Generation in Human Factor IX Concentrates. British Journal of Haematology 31: 25-35
• 14 Smith JK, Snape TJ, Bidwell E, EDWARds R, Gunson HH. 1977; Preparation of Factor IX Concentrate from Platelet-rich Plasma. Thrombosis and Haemostasis 37: 363-366
• 15 White GC, Roberts HR, Kingdon HS, Lundblad RL. 1977; Prothrombin Complex Concentrates: Potentially Thrombogenic Materials and Clues to the Mechanism of Thrombosis in vivo. Blood 49: 159-170